BIOMAT Database Logo BIOMAT Database Logo

Effect of opiate receptor blockade on the insulin response to oral glucose load in polycystic ovarian disease. 1991

A Lanzone, and A M Fulghesu, and A Fortini, and G Cutillo, and F Cucinelli, and N Di Simone, and A Caruso, and S Mancuso
Department of Obstetrics and Gynaecology, Università Cattolica del S. Cuore, Rome, Italy.

In order to test the hypothesis that endogenous opiates are at least partially responsible for hyperinsulinaemia in patients with polycystic ovarian disease (PCOD), the effect of naloxone (an opiate receptor blocker) on the insulin response to oral glucose load (OGTT) was studied in 20 women with PCOD and 17 control subjects at days 5-8 of their follicular phase. After fasting overnight for 10-12 h, each woman received an i.v. bolus injection (2 mg) of naloxone or an equal volume of saline infusion followed by a constant infusion of naloxone or saline solution at a rate of 8 ml/h (1 mg/h of naloxone) for 5 h. OGTT (75 g) was performed 1 h after the bolus injection. The naloxone study was performed 48 h after the saline study. Naloxone did not modify the insulin response to OGTT in either group. When the data were related to the insulin response, in PCOD hyperinsulinaemic patients, naloxone significantly reduced (P less than 0.02) the insulin response to OGTT without any change in glycaemic response curves. In control and PCOD normoinsulinaemic patients, naloxone did not change significantly either the glycaemia or the insulin levels after OGTT. No change of gonadotrophin and steroid secretion was found in any patient receiving naloxone. In conclusion, endogenous opiates may play a significant role in hyperinsulinaemia in PCOD.

UI MeSH Term Description Entries
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D009270 Naloxone A specific opiate antagonist that has no agonist activity. It is a competitive antagonist at mu, delta, and kappa opioid receptors. MRZ 2593-Br,MRZ-2593,Nalone,Naloxon Curamed,Naloxon-Ratiopharm,Naloxone Abello,Naloxone Hydrobromide,Naloxone Hydrochloride,Naloxone Hydrochloride Dihydride,Naloxone Hydrochloride, (5 beta,9 alpha,13 alpha,14 alpha)-Isomer,Naloxone, (5 beta,9 alpha,13 alpha,14 alpha)-Isomer,Narcan,Narcanti,Abello, Naloxone,Curamed, Naloxon,Dihydride, Naloxone Hydrochloride,Hydrobromide, Naloxone,Hydrochloride Dihydride, Naloxone,Hydrochloride, Naloxone,MRZ 2593,MRZ 2593 Br,MRZ 2593Br,MRZ2593,Naloxon Ratiopharm
D009292 Narcotic Antagonists Agents inhibiting the effect of narcotics on the central nervous system. Competitive Opioid Antagonist,Narcotic Antagonist,Opioid Antagonist,Opioid Antagonists,Opioid Receptor Antagonist,Opioid Reversal Agent,Competitive Opioid Antagonists,Opioid Receptor Antagonists,Opioid Reversal Agents,Agent, Opioid Reversal,Agents, Opioid Reversal,Antagonist, Competitive Opioid,Antagonist, Narcotic,Antagonist, Opioid,Antagonist, Opioid Receptor,Antagonists, Competitive Opioid,Antagonists, Narcotic,Antagonists, Opioid,Antagonists, Opioid Receptor,Opioid Antagonist, Competitive,Opioid Antagonists, Competitive,Receptor Antagonist, Opioid,Receptor Antagonists, Opioid,Reversal Agent, Opioid,Reversal Agents, Opioid
D011085 Polycystic Ovary Syndrome A complex disorder characterized by infertility, HIRSUTISM; OBESITY; and various menstrual disturbances such as OLIGOMENORRHEA; AMENORRHEA; ANOVULATION. Polycystic ovary syndrome is usually associated with bilateral enlarged ovaries studded with atretic follicles, not with cysts. The term, polycystic ovary, is misleading. Stein-Leventhal Syndrome,Polycystic Ovarian Syndrome,Polycystic Ovary Syndrome 1,Sclerocystic Ovarian Degeneration,Sclerocystic Ovaries,Sclerocystic Ovary Syndrome,Ovarian Degeneration, Sclerocystic,Ovarian Syndrome, Polycystic,Ovary Syndrome, Polycystic,Ovary, Sclerocystic,Sclerocystic Ovary,Stein Leventhal Syndrome,Syndrome, Polycystic Ovary,Syndrome, Stein-Leventhal
D001786 Blood Glucose Glucose in blood. Blood Sugar,Glucose, Blood,Sugar, Blood
D001835 Body Weight The mass or quantity of heaviness of an individual. It is expressed by units of pounds or kilograms. Body Weights,Weight, Body,Weights, Body
D004723 Endorphins One of the three major groups of endogenous opioid peptides. They are large peptides derived from the PRO-OPIOMELANOCORTIN precursor. The known members of this group are alpha-, beta-, and gamma-endorphin. The term endorphin is also sometimes used to refer to all opioid peptides, but the narrower sense is used here; OPIOID PEPTIDES is used for the broader group. Endorphin
D005260 Female Females
D005951 Glucose Tolerance Test A test to determine the ability of an individual to maintain HOMEOSTASIS of BLOOD GLUCOSE. It includes measuring blood glucose levels in a fasting state, and at prescribed intervals before and after oral glucose intake (75 or 100 g) or intravenous infusion (0.5 g/kg). Intravenous Glucose Tolerance,Intravenous Glucose Tolerance Test,OGTT,Oral Glucose Tolerance,Oral Glucose Tolerance Test,Glucose Tolerance Tests,Glucose Tolerance, Oral
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

A Lanzone, and A M Fulghesu, and A Fortini, and G Cutillo, and F Cucinelli, and N Di Simone, and A Caruso, and S Mancuso
Plasma insulin response to oral glucose load in Menière's disease.
January 1988, American journal of otolaryngology,
A Lanzone, and A M Fulghesu, and A Fortini, and G Cutillo, and F Cucinelli, and N Di Simone, and A Caruso, and S Mancuso
Plasma insulin response to oral glucose load in Menière's disease.
January 1986, American journal of otolaryngology,
A Lanzone, and A M Fulghesu, and A Fortini, and G Cutillo, and F Cucinelli, and N Di Simone, and A Caruso, and S Mancuso
Effect of protein ingestion on the glucose and insulin response to a standardized oral glucose load.
January 1984, Diabetes care,
A Lanzone, and A M Fulghesu, and A Fortini, and G Cutillo, and F Cucinelli, and N Di Simone, and A Caruso, and S Mancuso
Plasma insulin response to an oral glucose load in noncoronary heart disease.
February 1971, Chest,
A Lanzone, and A M Fulghesu, and A Fortini, and G Cutillo, and F Cucinelli, and N Di Simone, and A Caruso, and S Mancuso
Effects of cholinergic blockade by pirenzepine on insulin and glucose response to oral and intravenous glucose and to arginine load in obesity.
January 1997, Journal of endocrinological investigation,
A Lanzone, and A M Fulghesu, and A Fortini, and G Cutillo, and F Cucinelli, and N Di Simone, and A Caruso, and S Mancuso
Plasma insulin response to oral glucose load in hepatic cirrhosis.
September 1983, The Indian journal of medical research,
A Lanzone, and A M Fulghesu, and A Fortini, and G Cutillo, and F Cucinelli, and N Di Simone, and A Caruso, and S Mancuso
Impact of oral anticholinergic on insulin response to oral glucose load in patients with impaired glucose tolerance.
January 2021, Indian journal of pharmacology,
A Lanzone, and A M Fulghesu, and A Fortini, and G Cutillo, and F Cucinelli, and N Di Simone, and A Caruso, and S Mancuso
The effect of metoprolol on the glucose, insulin and glucagon response to glucose oral load in normal and diabetic subjects.
January 1983, Panminerva medica,
A Lanzone, and A M Fulghesu, and A Fortini, and G Cutillo, and F Cucinelli, and N Di Simone, and A Caruso, and S Mancuso
Effect of hyperprolactinemia on the androgen response to an oral glucose load.
December 1992, Fertility and sterility,
A Lanzone, and A M Fulghesu, and A Fortini, and G Cutillo, and F Cucinelli, and N Di Simone, and A Caruso, and S Mancuso
The effect of surgical stress on insulin sensitivity, glucose effectiveness and acute insulin response to glucose load.
May 2003, Journal of endocrinological investigation,
Copied contents to your clipboard!